Psymed Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
- Paid Up Capital ₹ 1.05 Cr
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 0.62%
- Profit Growth -86.06%
- Ebitda 29.29%
- Net Worth 1.72%
- Total Assets 178.42%
About Psymed Hospitals
Psymed Hospitals Private Limited (PHPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 June 2010 and has a history of 14 years and eight months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Setlin Venkatesh, Venkatesh Ramachandran, Rangarajan Narayanan, and One other member serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110TN2010PTC076022
-
Company No.
076022
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jun 2010
-
Date of AGM
09 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Psymed Hospitals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatesh Ramachandran
|
Managing Director | 04-Jun-2010 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Setlin Venkatesh
|
Whole-Time Director | 04-Jun-2010 | Current |
|
Rangarajan Narayanan
|
Whole-Time Director | 04-Jun-2010 | Current |
|
Sureshkumar Munirathinam
|
Whole-Time Director | 04-Jun-2010 | Current |
Financial Performance of Psymed Hospitals.
Psymed Hospitals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.62% increase. The company also saw a substantial fall in profitability, with a 86.06% decrease in profit. The company's net worth moved up by a moderate rise of 1.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Psymed Hospitals?
In 2020, Psymed Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Phrenos Pharma Private LimitedSetlin Venkatesh is a mutual person
-
Psymed Hospital Research Llp
Venkatesh Ramachandran and Sureshkumar Munirathinam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Psymed Hospitals?
Unlock and access historical data on people associated with Psymed Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Psymed Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Psymed Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
